---
figid: PMC5849167__oncotarget-09-12705-g005
figtitle: Ang-2 up-regulating EMT and facilitating lung cancer metastasis
organisms:
- Bos taurus
- Oryctolagus cuniculus
- Capra hircus
- Equus caballus
- Homo sapiens
- Mus musculus
- Armoracia rusticana
pmcid: PMC5849167
filename: oncotarget-09-12705-g005.jpg
figlink: /pmc/articles/PMC5849167/figure/F5/
number: F5
caption: Ang-2 has been implicated in mediating inflammatory processes, and upregulated
  in multiple inflammation-related tumors or signaling pathway. With lung cancer volume
  increasing, intratumoral hypoxia in the absence of vascularization resulted in tumor
  cells to express Ang-2 inducing angiogenesis for tumor growth and increasing vascular
  permeability. Overexpression of Ang-2 facilitating proliferation, invasion, metastasis,
  and EMT of lung cancer cells that could be a new mechanism insight into tumor metastasis
  by inhibiting E-cadherin and upregulating VIM, Twist and Snail signaling. Ang, angiopoietin;
  Ang-2, angiopoietin-2; CaMK, calcium/calmodulin-dependent protein kinase; EMT, epithelial-mesenchymal
  transition; ENO1, enolase 1; EPO, erythropoietin; ET1, endothelin-1; GAPDH, glyceraldehyde-3-phosphate
  dehydrogenase; Glut1, glucose transporter 1; HIF-1α, hypoxia-inducible factor-1α;
  HK1, hexokinase 1; HRE, hypoxia-response element; IGF2, insulin-like growth factor
  2; IP3, inositol 1,4,5-trisphate; mTOR, mechanistic target of rapamycin kinase;
  NOS2, nitric oxide synthase 2; Oncogenes, ras, c-myc etc; PLC-γ, phospholipase C
  gamma; PI3K, phosphatidylinositol 3-kinase; PKC, protein kinase C; RTK, receptor
  tyrosine kinase; TGFA, transforming growth factor alpha; tumor suppressor genes,
  pVHL, P53, PTEN, etc. VEGF, vascular endothelial growth factors; VHL, von Hippel-Lidau;
  VIM, Vimentin.
papertitle: Ang-2 promotes lung cancer metastasis by increasing epithelial-mesenchymal
  transition.
reftext: Zhizhen Dong, et al. Oncotarget. 2018 Feb 27;9(16):12705-12717.
year: '2018'
doi: .na.character
journal_title: .na.character
journal_nlm_ta: .na.character
publisher_name: .na.character
keywords: .na.character
automl_pathway: 0.9668442
figid_alias: PMC5849167__F5
figtype: Figure
organisms_ner:
- Bos taurus
- Mus musculus
- Capra hircus
- Equus caballus
- Oryctolagus cuniculus
- Homo sapiens
redirect_from: /figures/PMC5849167__F5
ndex: 02625cf9-debc-11ea-99da-0ac135e8bacf
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC5849167__oncotarget-09-12705-g005.html
  '@type': Dataset
  description: Ang-2 has been implicated in mediating inflammatory processes, and
    upregulated in multiple inflammation-related tumors or signaling pathway. With
    lung cancer volume increasing, intratumoral hypoxia in the absence of vascularization
    resulted in tumor cells to express Ang-2 inducing angiogenesis for tumor growth
    and increasing vascular permeability. Overexpression of Ang-2 facilitating proliferation,
    invasion, metastasis, and EMT of lung cancer cells that could be a new mechanism
    insight into tumor metastasis by inhibiting E-cadherin and upregulating VIM, Twist
    and Snail signaling. Ang, angiopoietin; Ang-2, angiopoietin-2; CaMK, calcium/calmodulin-dependent
    protein kinase; EMT, epithelial-mesenchymal transition; ENO1, enolase 1; EPO,
    erythropoietin; ET1, endothelin-1; GAPDH, glyceraldehyde-3-phosphate dehydrogenase;
    Glut1, glucose transporter 1; HIF-1α, hypoxia-inducible factor-1α; HK1, hexokinase
    1; HRE, hypoxia-response element; IGF2, insulin-like growth factor 2; IP3, inositol
    1,4,5-trisphate; mTOR, mechanistic target of rapamycin kinase; NOS2, nitric oxide
    synthase 2; Oncogenes, ras, c-myc etc; PLC-γ, phospholipase C gamma; PI3K, phosphatidylinositol
    3-kinase; PKC, protein kinase C; RTK, receptor tyrosine kinase; TGFA, transforming
    growth factor alpha; tumor suppressor genes, pVHL, P53, PTEN, etc. VEGF, vascular
    endothelial growth factors; VHL, von Hippel-Lidau; VIM, Vimentin.
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - VHL
  - PIK3CB
  - AKT1
  - ENO1
  - GAPDH
  - EPO
  - ADM
  - VIM
  - CDH1
  - GPI
  - PGK1
  - NOS2
  - NANOS2
  - IGF2
  - TGFA
  - MTOR
  - VEGFA
  - HIF1A
  - PC
  - Trp53
  - Vhl
  - ras
  - Hras
  - Kras
  - Rem1
  - Decr1
  - Pik3r1
  - Akt1
  - Itk
  - Slc22a3
  - Eno1
  - Eno1b
  - Gapdh
  - Epo
  - Epx
  - Adm
  - Vim
  - Cdh1
  - Fzr1
  - Gpi1
  - Pgk1
  - Vcan
  - Nos2
  - Nanos2
  - Igf2
  - D7Zem1
  - D7Zem3
  - D7Zem2
  - Tgfa
  - Mtor
  - Vegfa
  - Camk1
  - Ep300
  - Crebbp
  - Pag1
  - Cytip
  - Hif1a
  - pk
  - Twist1
  - Edn1
  - D9Mgc40e
  - pc
  - TP53
  - ENO3
  - PGM1
  - EDN1
  - TP63
  - TP73
  - KRAS
  - HRAS
  - NRAS
  - DECR1
  - PIK3CA
  - PIK3CD
  - PIK3CG
  - PIK3R3
  - PIK3R4
  - PIK3R5
  - PIK3R6
  - PIK3R1
  - PIK3R2
  - AKT2
  - AKT3
  - ITK
  - SLC22A3
  - ALDOA
  - GAPDHP44
  - TIMP1
  - EPX
  - FZR1
  - GNPDA1
  - HK1
  - VCAN
  - VEGFB
  - VEGFC
  - VEGFD
  - PGF
  - PRRT2
  - PRKCA
  - PRKCB
  - PRKCD
  - PRKCE
  - PRKCG
  - PRKCH
  - PRKCI
  - PRKCQ
  - PRKCZ
  - PRKD3
  - CAMK4
  - CAMK2G
  - CAMK1
  - CAMK1D
  - CAMK1G
  - CAMK2A
  - CAMK2B
  - CAMK2D
  - EP300
  - CREBBP
  - EIF4E
  - OPN1LW
  - PAG1
  - PCBP4
  - TWIST1
  - NADPH
  - ENO1
  - Ca
  - Lung cancer
  - VHL
  - hypoxic
---
